| 12064419 |
Methods of using RAD51 inhibitors for treatment of pancreatic cancer |
Alfredo C. Castro, Melinda DAY, Tyler MACLAY, Kevin MILLS, Joseph P. Vacca |
2024-08-20 |
|
| 11932636 |
RAD51 inhibitors |
Jean-Marc Lapierre, Joseph P. Vacca |
2024-03-19 |
|
| 11607404 |
Combinations of RAD51 and PARP inhibitors |
Alfredo C. Castro, Melinda DAY, Tyler MACLAY, Kevin MILLS, Joseph P. Vacca |
2023-03-21 |
$1,322,000 |
| 11291655 |
RAD51 inhibitors |
Alfredo C. Castro, Joseph P. Vacca |
2022-04-05 |
$3,401,000 |
| 11247988 |
RAD51 inhibitors |
Jean-Marc Lapierre, Joseph P. Vacca |
2022-02-15 |
$5,020,000 |
| 11084812 |
RAD51 inhibitors |
Alfredo C. Castro, Joseph P. Vacca, Tyler MACLAY |
2021-08-10 |
$17,783,000 |
| 11001592 |
DNA polymerase IIIC inhibitors and use thereof |
Xiang Yu, Li Xing, Minghua Wang, Michael SILVERMAN, Richard Soll |
2021-05-11 |
|
| 10836772 |
DNA polymerase IIIC inhibitors and use thereof |
Xiang Yu, Li Xing, Minghua Wang, Michael SILVERMAN, Richard Soll |
2020-11-17 |
|
| 10723741 |
DNA polymerase IIIC inhibitors and use thereof |
Xiang Yu, Li Xing, Minghua Wang, Michael SILVERMAN, Richard Soll |
2020-07-28 |
|
| 10590122 |
RAD51 inhibitors |
Alfredo C. Castro, Joseph P. Vacca, Tyler MACLAY |
2020-03-17 |
|
| 10562909 |
Fused quadracyclic compounds, compositions and uses thereof |
Michael H. Serrano-Wu, Joseph P. Vacca |
2020-02-18 |
|
| 10336746 |
RAD51 inhibitors |
Alfredo C. Castro, Joseph P. Vacca, Tyler MACLAY |
2019-07-02 |
|
| 10059718 |
Fused quadracyclic compounds, compositions and uses thereof |
Michael H. Serrano-Wu, Joseph P. Vacca |
2018-08-28 |
|
| 9914736 |
TrKA kinase inhibitors, compositions and methods thereof |
Helen J. Mitchell, Mark E. Fraley, Andrew Cooke, Craig A. Stump, Xu-Fang Zhang +6 more |
2018-03-13 |
$78,687,000 |
| 9862716 |
TRKA kinase inhibitors, compositions and methods thereof |
Helen J. Mitchell, Mark E. Fraley, Andrew Cooke, Craig A. Stump, Yi-Heng Chen +10 more |
2018-01-09 |
$60,079,000 |
| 9815846 |
TrkA kinase inhibitors, compositions and methods thereof |
Helen J. Mitchell, Mark E. Fraley, Andrew Cooke, Craig A. Stump, Yi-Heng Chen +13 more |
2017-11-14 |
$82,691,000 |
| 9663513 |
Pyrimidine PDE10 inhibitors |
Scott D. Kuduk, Thomas S. Reger |
2017-05-30 |
$63,958,000 |
| 9573939 |
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases |
Nigel J. Liverton, Joerg Habermann, Uwe Koch, Frank Narjes, Peng Li +8 more |
2017-02-21 |
$159,401,000 |
| 9549921 |
Heterocyclic compounds and methods of use thereof for the treatment of hepatitis C |
Shuwen He, Zhong Lai, Xing Dai, Dong Xiao, Clare London +6 more |
2017-01-24 |
$89,126,000 |
| 9549917 |
Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases |
Nigel J. Liverton, Joerg Habermann, Uwe Koch, Frank Narjes, Peng Li +10 more |
2017-01-24 |
$89,126,000 |
| 9364482 |
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases |
Xing Dai, Hong Liu, Anandan Palani, Shuwen He, Ravi Nargund +6 more |
2016-06-14 |
$59,713,000 |
| 9353104 |
Substituted pyridizinone derivatives as PDE10 inhibitors |
Scott D. Kuduk, Thomas S. Reger, Changhe Qi |
2016-05-31 |
$68,752,000 |
| 9284302 |
Cyclobutyl benzimidazoles as PDE 10 inhibitors |
Scott D. Kuduk, Thomas S. Reger |
2016-03-15 |
$52,961,000 |
| 9273033 |
Substituted pyridone derivatives as PDE10 inhibitors |
Scott D. Kuduk, Thomas S. Reger |
2016-03-01 |
$86,173,000 |
| 9265773 |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases |
Nigel J. Liverton, Joerg Habermann, Uwe Koch, Frank Narjes, Peng Li +12 more |
2016-02-23 |
$104,084,000 |
